Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Biochemical Pharmacology|November 23, 2005
Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonistsKazuya Yamano, Miho Inoue, Shigehiro Masaki, et al.
Biochemical Pharmacology|September 15, 2005
Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in miceKazuya Yamano, Miho Inoue, Shigehiro Masaki, et al.
Transgenic Research|March 28, 2007
Identification of the functional expression of adenosine A3 receptor in pancreas using transgenic mice expressing jellyfish apoaequorinKazuya Yamano, Katsuhiro Mori, Ryosuke Nakano, et al.
Cancer Science|June 23, 2009
Engineered therapeutic antibodies with improved effector functionsTsuguo Kubota, Rinpei Niwa, Mitsuo Satoh, et al.
BMC Biotechnology|December 1, 2007
Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCCHarue Imai-Nishiya, Katsuhiro Mori, Miho Inoue, et al.
Experimental Hematology|February 17, 2009
Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophilsMami Shibata-Koyama, Shigeru Iida, Hirofumi Misaka, et al.
Cell Transplantation|May 25, 2006
One-step induction of neurons from mouse embryonic stem cells in serum-free media containing vitamin B12 and heparinHironori Yamazoe, Masato Kobori, Yoshinobu Murakami, et al.
Journal of Immunological Methods|October 13, 2005
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharidesRinpei Niwa, Akito Natsume, Aya Uehara, et al.
BMC Cancer|February 20, 2009
Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human bloodShigeru Iida, Reiko Kuni-Kamochi, Katsuhiro Mori, et al.
Plos One|October 8, 2015
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ ReceptorsYuya Isoda, Hirokazu Yagi, Tadashi Satoh, et al.
Pageof 4